These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7481305)

  • 21. [Antisense constructs, therapeutics of the future?].
    Van Aerschot A
    Verh K Acad Geneeskd Belg; 2000; 62(6):565-601. PubMed ID: 11196580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peptide-oligonucleotide conjugates as a new generation of antisense elements].
    Stetsenko DA; Arzumanov AA; Korshun VA; Gait MJ
    Mol Biol (Mosk); 2000; 34(6):998-1006. PubMed ID: 11186016
    [No Abstract]   [Full Text] [Related]  

  • 23. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress in antisense therapeutics.
    Crooke ST
    Hematol Pathol; 1995; 9(2):59-72. PubMed ID: 7559256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense 98: work in progress.
    Nat Biotechnol; 1998 Dec; 16(13):1319-21. PubMed ID: 9853610
    [No Abstract]   [Full Text] [Related]  

  • 26. Technology evaluation: ISIS-2503, Isis Pharmaceuticals.
    Morse MA
    Curr Opin Mol Ther; 2001 Dec; 3(6):589-94. PubMed ID: 11804274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antisense strategy--new trends].
    Koziołkiewicz M
    Postepy Biochem; 1998; 44(2):125-35. PubMed ID: 9770236
    [No Abstract]   [Full Text] [Related]  

  • 28. Antisense oligonucleotides in the design of new therapeutic strategies.
    Piulats J; Tarrasón G
    Methods Find Exp Clin Pharmacol; 1997; 19 Suppl A():31-2. PubMed ID: 9403853
    [No Abstract]   [Full Text] [Related]  

  • 29. Antisense strategy in hematological malignancies.
    Warzocha K
    Cytokines Cell Mol Ther; 1999 Mar; 5(1):15-23. PubMed ID: 10390076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
    White PJ; Anastasopoulos F; Pouton CW; Boyd BJ
    Expert Rev Mol Med; 2009 Mar; 11():e10. PubMed ID: 19302730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of antisense nucleotides for therapy].
    Wang J; Wang L; Wang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):230-4. PubMed ID: 16532848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential.
    Olie RA; Zangemeister-Wittke U
    Drug Resist Updat; 2001 Feb; 4(1):9-15. PubMed ID: 11512155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical and clinical experience of antisense therapy for solid tumors.
    Webb MS; Zon G
    Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular uptake and intracellular fate of antisense oligonucleotides.
    Thierry AR; Vives E; Richard JP; Prevot P; Martinand-Mari C; Robbins I; Lebleu B
    Curr Opin Mol Ther; 2003 Apr; 5(2):133-8. PubMed ID: 12772502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Making sense of antisense and interference.
    Morrow T
    Manag Care; 2003 Nov; 12(11):62-3. PubMed ID: 14666589
    [No Abstract]   [Full Text] [Related]  

  • 36. Antisense oligonucleotides targeting p53.
    Barton C; Lemoine N
    J Clin Oncol; 1997 Jan; 15(1):408. PubMed ID: 8996169
    [No Abstract]   [Full Text] [Related]  

  • 37. Progress in antisense technology: the end of the beginning.
    Crooke ST
    Methods Enzymol; 2000; 313():3-45. PubMed ID: 10595347
    [No Abstract]   [Full Text] [Related]  

  • 38. A listing of antisense patents, 1971-1991.
    Antisense Res Dev; 1991; 1(2):219-26. PubMed ID: 1841664
    [No Abstract]   [Full Text] [Related]  

  • 39. Probing the function of novel genes in the nervous system: is antisense the answer?
    Hunter AJ; Leslie RA; Gloger IS; Lawrence M
    Trends Neurosci; 1995 Aug; 18(8):329-31. PubMed ID: 7482791
    [No Abstract]   [Full Text] [Related]  

  • 40. Oligonucleotides make sensible strides.
    Doran G
    Drug Discov Today; 2004 Feb; 9(3):114-6. PubMed ID: 14960388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.